Three insights:
1. Talomon Capital likely amassed its entire stake in Surgery Partners in recent weeks.
2. Talomon Capital manages about $307 million for clients, meaning its investment in Surgery Partners accounts for about 5 percent of its total investments.
3. The value of Surgery Partners’ shares has dropped two-thirds in the past year. Several top executives have left the company, which is working to close a federal investigation into its drug-testing practices.
More articles on transactions and valuation:
Connecticut hospital weighs investing in surgery center — 5 insights
Physicians Endoscopy names new CEO & more — 9 ASC industry notes
California HCA ASC real estate listed for sale at $7M
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
